TRELYPSO
LIVE

Serial Number

79273115

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Oct 3, 2019

Add to watchlist:

No watchlists yet
View on USPTO

TRELYPSO Trademark

Serial Number: 79273115 • Registration: 6031662

TRELYPSO is a trademark filed by NOVARTIS AG on October 3, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

October 3, 2019

Registration Date

April 14, 2020

Published for Opposition

January 28, 2020

Cancellation Date

September 22, 2022

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 11, 2023 DENC
DEATH OF INTERNATIONAL REGISTRATION
Apr 11, 2023 DETH
NOTIFICATION PROCESSED BY IB
Jun 5, 2020 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
May 20, 2020 FICS
FINAL DISPOSITION PROCESSED
May 20, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
May 14, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Apr 14, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 28, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jan 28, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 8, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 20, 2019 CNSA
ASSIGNED TO EXAMINER
Dec 13, 2019 DOCK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 12, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 12, 2019 REAP
APPLICATION FILING RECEIPT MAILED
Dec 7, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 2, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Nov 28, 2019 SDRC